No Detail Found!

IMMUNOHISTOCHEMICAL EXPRESSION OF ANDROGEN RECEPTOR IN TRIPLE NEGATIVE BREAST CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY, RAWALPINDI

Author(s)
Amna Ameer Armed Forces Institute of Pathology, Rawalpindi Pakistan
Farhan Akhtar Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi, Rawalpindi Pakistan
Hafeez Ud Din Armed Forces Institute of Pathology, Rawalpindi Pakistan
Rabia Ahmed Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abstract
Objective: To determine the frequency of immunohistochemical expression of androgen receptor in triple negative breast carcinoma. Study Design: Cross sectional study. Duration and Place of Study: This study included 30 cases confirmed as triple negative breast carcinoma at Armed Forces Institute of Pathology Rawalpindi, from Jan to Jul 2018. Methodology: Anti-androgen receptor antibody was applied and assessed. Positive expression was defined as greater and equal to 10% nuclear immunostaining. SPSS-24 was used for analyzing data. Results: Out of 30 cases of triple negative breast carcinoma (TNBC), all patients were female. Patients' ages ranged between 21-72 years with a mean age of 46.35 years and a standard deviation of ± 13.4. Androgen receptor expression was positive in 8 cases (27%) of all triple negative breast carcinomas. Out of these androgen receptor (AR) triple negative breast carcinomas; all 8 cases were of histological subtype invasive ductal (mammary) carcinoma, non special type, 7 cases (23%) were of histological grade 3 and 1 was of histological grade 2. Conclusion: Androgen receptor expression is observed in 8 cases (27%) of triple negative breast carcinoma cases. Such patients can be selected as candidates for anti- androgen receptor targeted therapy.
Publication Details
Page(s) 7-11
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 71, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Prognosis, breast carcinoma, androgen receptor, Triple negative breast carcinoma., Hormone receptors
0

Citations

0

Downloads

56

Views